University of California San Francisco

Publications

  1. Prenatal Delivery of Enzyme Replacement Therapy to Fetuses Affected by Early-Onset Lysosomal Storage Diseases.
    2025 | PubMed
  2. Dual α-globin-truncated erythropoietin receptor knockin restores hemoglobin production in α-thalassemia-derived erythroid cells.
    2025 | PubMed
  3. In utero hematopoietic stem cell transplantation for Fanconi anemia.
    2024 | PubMed
  4. The Conundrum of Mechanics Versus Genetics in Congenital Hydrocephalus and Its Implications for Fetal Therapy Approaches: A Scoping Review.
    2024 | PubMed
  5. Dual α-globin and truncated EPO receptor knockin restores hemoglobin production in α-thalassemia-derived red blood cells.
    2024 | PubMed
  6. Prenatal AAV9-GFP administration in fetal lambs results in transduction of female germ cells and maternal exposure to virus.
    2024 | PubMed
  7. Prenatal delivery of a therapeutic antisense oligonucleotide achieves broad biodistribution in the brain and ameliorates Angelman syndrome phenotype in mice.
    2024 | PubMed
  8. Intrauterine enzyme replacement therapies for lysosomal storage disorders: Current developments and promising future prospects.
    2023 | PubMed
  9. Systematic evaluation of genome sequencing for the diagnostic assessment of autism spectrum disorder and fetal structural anomalies.
    2023 | PubMed
  10. Are we prepared to deliver gene-targeted therapies for rare diseases?
    2023 | PubMed
  11. The impact of in utero transfusions on perinatal outcomes in patients with alpha thalassemia major: the UCSF registry.
    2023 | PubMed
  12. In Utero Enzyme-Replacement Therapy for Infantile-Onset Pompe's Disease.
    2022 | PubMed
  13. Investigating attitudes toward prenatal diagnosis and fetal therapy for spinal muscular atrophy.
    2022 | PubMed
  14. Prenatal Somatic Cell Gene Therapies: Charting a Path Toward Clinical Applications (Proceedings of the CERSI-FDA Meeting).
    2022 | PubMed
  15. Thymic and extrathymic Aire-expressing cells in maternal-fetal tolerance.
    2022 | PubMed
  16. Fetal therapies and trials for lysosomal storage diseases: a survey of attitudes of parents and patients.
    2022 | PubMed
  17. Consensus statement for the perinatal management of patients with α thalassemia major.
    2021 | PubMed
  18. Advances in the management of α-thalassemia major: reasons to be optimistic.
    2021 | PubMed
  19. Prenatal Gene Therapy.
    2021 | PubMed
  20. Maternal and Infant Immune Repertoire Sequencing Analysis Identifies Distinct Ig and TCR Development in Term and Preterm Infants.
    2021 | PubMed
  21. Exome sequencing of fetuses with congenital diaphragmatic hernia supports a causal role for NR2F2, PTPN11, and WT1 variants.
    2021 | PubMed
  22. Extrathymic Aire-expressing cells support maternal-fetal tolerance.
    2021 | PubMed
  23. Forever Connected: The Lifelong Biological Consequences of Fetomaternal and Maternofetal Microchimerism.
    2021 | PubMed
  24. Fetal and Maternal Safety Considerations for In Utero Therapy Clinical Trials: iFeTiS Consensus Statement.
    2020 | PubMed
  25. Exome Sequencing for Prenatal Diagnosis in Nonimmune Hydrops Fetalis.
    2020 | PubMed
  26. Detection of microbial cell-free DNA in maternal and umbilical cord plasma in patients with chorioamnionitis using next generation sequencing.
    2020 | PubMed
  27. Tolerance induction and microglial engraftment after fetal therapy without conditioning in mice with Mucopolysaccharidosis type VII.
    2020 | PubMed
  28. CD161 contributes to prenatal immune suppression of IFNγ-producing PLZF+ T cells.
    2019 | PubMed
  29. In Utero Gene Therapy Consensus Statement from the IFeTIS.
    2019 | PubMed
  30. Evaluation of Clinical Outcomes of Sutureless vs Sutured Closure Techniques in Gastroschisis Repair.
    2019 | PubMed
  31. Depletion of murine fetal hematopoietic stem cells with c-Kit receptor and CD47 blockade improves neonatal engraftment.
    2018 | PubMed
  32. Large Differences in Small RNA Composition Between Human Biofluids.
    2018 | PubMed
  33. Future AAVenues for In Utero Gene Therapy.
    2018 | PubMed
  34. Meta-Analysis of Maternal and Fetal Transcriptomic Data Elucidates the Role of Adaptive and Innate Immunity in Preterm Birth.
    2018 | PubMed
  35. Alloreactive fetal T cells promote uterine contractility in preterm labor via IFN-γ and TNF-α.
    2018 | PubMed
  36. Systemic multilineage engraftment in mice after in utero transplantation with human hematopoietic stem cells.
    2018 | PubMed
  37. Esophagoesophagopexy technique for assisted fistulization of esophageal atresia.
    2017 | PubMed
  38. Non-Immune Hydrops Fetalis: Do Placentomegaly and Polyhydramnios Matter?
    2017 | PubMed
  39. Sacrococcygeal teratoma: late recurrence warrants long-term surveillance.
    2017 | PubMed
  40. Fetal stem cell and gene therapy.
    2017 | PubMed
  41. Epidemiology of Live Born Infants with Nonimmune Hydrops Fetalis-Insights from a Population-Based Dataset.
    2017 | PubMed
  42. Favorable outcomes after in utero transfusion in fetuses with alpha thalassemia major: a case series and review of the literature.
    2016 | PubMed
  43. A Transient Developmental Hematopoietic Stem Cell Gives Rise to Innate-like B and T Cells.
    2016 | PubMed
  44. Magnetic resonance imaging of Müllerian duct anomalies in children.
    2016 | PubMed
  45. Heightened Immune Activation in Fetuses with Gastroschisis May Be Blocked by Targeting IL-5.
    2016 | PubMed
  46. Mass Effect Alone May Not Explain Pulmonary Vascular Pathology in Severe Congenital Diaphragmatic Hernia.
    2015 | PubMed
  47. Fetal Surgical conditions and the unraveling of maternal-fetal tolerance.
    2015 | PubMed
  48. A booster shot to cure hemoglobinopathies.
    2015 | PubMed
  49. Maternal factors associated with the occurrence of gastroschisis.
    2015 | PubMed
  50. Increased maternal T cell microchimerism in the allogeneic fetus during LPS-induced preterm labor in mice.
    2015 | PubMed
  51. Consensus statement from the first international conference for in utero stem cell transplantation and gene therapy.
    2015 | PubMed
  52. In utero hematopoietic cell transplantation for hemoglobinopathies.
    2015 | PubMed
  53. Placental drug delivery for treatment of congenital hematopoietic disorders.
    2014 | PubMed
  54. The many faces of hydrops.
    2014 | PubMed
  55. Novel non-surgical prenatal approaches to treating congenital diaphragmatic hernia.
    2014 | PubMed
  56. Favorable outcomes in high-risk congenital pulmonary airway malformations treated with multiple courses of maternal betamethasone.
    2014 | PubMed
  57. Maternal-fetal cellular trafficking: clinical implications and consequences.
    2014 | PubMed
  58. In utero depletion of fetal hematopoietic stem cells improves engraftment after neonatal transplantation in mice.
    2014 | PubMed
  59. Memory regulatory T cells reside in human skin.
    2014 | PubMed
  60. Outcomes of fetal intervention for primary hydrothorax.
    2014 | PubMed
  61. Fetal intervention increases maternal T cell awareness of the foreign conceptus and can lead to immune-mediated fetal demise.
    2014 | PubMed
  62. Anal duplication in a one-year-old girl.
    2013 | PubMed
  63. Fetal production of growth factors and inflammatory mediators predicts pulmonary hypertension in congenital diaphragmatic hernia.
    2013 | PubMed
  64. Direct and indirect antigen presentation lead to deletion of donor-specific T cells after in utero hematopoietic cell transplantation in mice.
    2013 | PubMed
  65. Clinical implications of maternal-fetal cellular trafficking.
    2013 | PubMed
  66. Hepatic portocholecystostomy for biliary atresia: a 25-year follow-up and review.
    2013 | PubMed
  67. Type IV intestinal atresia, congenital bilateral perisylvian syndrome, and chronic pulmonary hypertension secondary to multiple vascular disruption syndrome in a monochorionic twin.
    2012 | PubMed
  68. The diagnosis and management of intradiaphragmatic extralobar pulmonary sequestrations: a report of 4 cases.
    2012 | PubMed
  69. Increased maternal microchimerism after open fetal surgery.
    2012 | PubMed
  70. Alterations in maternal-fetal cellular trafficking after fetal surgery.
    2012 | PubMed
  71. Long-term outcomes after fetal therapy for congenital high airway obstructive syndrome.
    2012 | PubMed
  72. In utero hematopoietic cell transplantation for the treatment of congenital anomalies.
    2012 | PubMed
  73. Maternal microchimerism in patients with biliary atresia: Implications for allograft tolerance.
    2012 | PubMed
  74. Decreased risk of graft failure with maternal liver transplantation in patients with biliary atresia.
    2011 | PubMed
  75. Pancreatic mesenchyme regulates epithelial organogenesis throughout development.
    2011 | PubMed
  76. The maternal immune response inhibits the success of in utero hematopoietic cell transplantation.
    2011 | PubMed
  77. A mouse model of in utero transplantation.
    2011 | PubMed
  78. Maternal T cells limit engraftment after in utero hematopoietic cell transplantation in mice.
    2011 | PubMed
  79. Image of the month--quiz case. Gastric duplication cyst.
    2010 | PubMed
  80. Long-term surgical outcomes in congenital diaphragmatic hernia: observations from a single institution.
    2010 | PubMed
  81. Persistent expression of hF.IX After tolerance induction by in utero or neonatal administration of AAV-1-F.IX in hemophilia B mice.
    2007 | PubMed
  82. Impact of continuous intraoperative monitoring on outcomes in open fetal surgery.
    2005 | PubMed
  83. Transduction of satellite cells after prenatal intramuscular administration of lentiviral vectors.
    2005 | PubMed
  84. Long-term transgene expression in cardiac and skeletal muscle following fetal administration of adenoviral or adeno-associated viral vectors in mice.
    2003 | PubMed
  85. Efficient transduction of liver and muscle after in utero injection of lentiviral vectors with different pseudotypes.
    2002 | PubMed
  86. The ex-utero intrapartum treatment.
    2002 | PubMed
  87. Engraftment of bone marrow and fetal liver cells after in utero transplantation in MDX mice.
    2002 | PubMed
  88. The natural history of prenatally diagnosed conjoined twins.
    2002 | PubMed
  89. Human mesenchymal stem cells: insights from a surrogate in vivo assay system.
    2002 | PubMed
  90. Risk factors for intermediate-term survival after coronary artery bypass grafting.
    2001 | PubMed
  91. Large-volume paracentesis in the management of ascites in children.
    2001 | PubMed
  92. Survival after first esophageal variceal hemorrhage in patients with biliary atresia.
    2001 | PubMed
  93. The management of prenatally diagnosed choledochal cysts.
    2001 | PubMed
  94. A fetal lung lesion consisting of bronchogenic cyst, bronchopulmonary sequestration, and congenital cystic adenomatoid malformation: the missing link?
    2001 | PubMed
  95. Human mesenchymal stem cells persist, demonstrate site-specific multipotential differentiation, and are present in sites of wound healing and tissue regeneration after transplantation into fetal sheep.
    2001 | PubMed
  96. Heterogeneity of type I diabetes: analysis of monozygotic twins in Great Britain and the United States.
    2001 | PubMed
  97. The impact of the diabetes control and complications trial and humalog insulin on glycohemoglobin levels and severe hypoglycemia in type 1 diabetes.
    2001 | PubMed
  98. Multilineage differentiation of human MSC after in utero transplantation.
    2001 | PubMed
  99. Human mesenchymal stem cells engraft and demonstrate site-specific differentiation after in utero transplantation in sheep.
    2000 | PubMed
  100. Response to treatment as a predictor of longterm outcome in patients with lupus nephritis.
    1994 | PubMed
  101. The time-dependence of long-term prediction in lupus nephritis.
    1994 | PubMed
  102. Can experienced clinicians predict the outcome of lupus nephritis?
    1992 | PubMed
  103. Cerebrovascular deaths before and after the appearance of oral contraceptives.
    1987 | PubMed
  104. Systemic and renal hemodynamic consequences of manipulation of serum calcium and/or parathyroid hormone in the intact conscious mongrel dog.
    1987 | PubMed
  105. Hemoglobin A1 in renal transplant recipients.
    1985 | PubMed
  106. Effect of clonidine therapy on renal hemodynamics in renal transplant hypertension.
    1984 | PubMed